MethylGene

Montreal, Quebec

TSX: MYG

MethylGene is a biopharmaceutical company focused on the discovery, development and commercialization of inhibitors for enzymes involved primarily in oncologic and infectious disease indications. The company uses functional genomics to validate enzyme targets and uses rational drug design and medicinal chemistry to design, synthesize and optimize enzyme inhibitors